关于苏州德龙激光股份有限公司 已投私募基金减资、参与投资新设私募基金暨关联交易的核查意见 中信建投证券股份有限公司（以下简称"中信建投证券"、"保荐机构"）作 为苏州德龙激光股份有限公司（以下简称"德龙激光"、"公司"）首次公开发行 股票并在科创板上市的保荐机构，根据《证券发行上市保荐业务管理办法》《上 海证券交易所科创板股票上市规则》等相关规定履行持续督导职责，对德龙激光 已投私募基金减资、参与投资新设私募基金暨关联交易事项进行了审慎核查，具 体情况如下： 一、本次关联交易概述 （一）苏州沃衍减资 公司于 2022 年 9 月 5 日召开第四届董事会第十一次会议审议通过了《关于 参与投资私募基金暨关联交易的议案》，同意公司作为有限合伙人使用自有资金 向苏州沃衍认缴出资 3,000 万元。具体情况详见 2022 年 9 月 7 日在上海证券交 易所官网（www.sse.com.cn）披露的《苏州德龙激光股份有限公司关于参与投资 私募基金暨关联交易的公告》（公告编号：2022-020）。 中信建投证券股份有限公司 为进一步优化基金结构，结合基金实际运作情况，基金管理人北京沃衍资本 管理中心（有限合伙）（以下简称 ...

证券代码：603825 证券简称：华扬联众 公告编号：2025-089 华扬联众数字技术股份有限公司 关于第六届监事会第九次（临时）会议决议的公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、 监事会会议召开情况 (一) 华扬联众数字技术股份有限公司（以下简称"公司"）第六届监事会 第九次（临时）会议（以下简称"本次会议"）的召开符合《中华人民共和国公 司法》和《公司章程》的有关规定。 具体内容详见公司披露的《关于公司与关联方共同投资设立合资公司暨关联 交易的公告》（公告编号：2025-068）、《关于公司与关联方共同投资设立合资 公司暨关联交易的进展公告》（公告编号：2025-090）。 二、监事会会议审议情况 全体监事经过认真审议和表决，形成如下决议： 案》 同意公司与控股股东湖南湘江新区发展集团有限公司共同投资设立合资公 司。 监事会认为，本次关联交易是双方在自愿、平等、互利的基础上协商确定， 符合交易公平原则。本次关联交易不影响公司独立性，不存在损害公司和股东利 益的情形。 表决结果：同意 2 票，反对 0 票 ...

Core Viewpoint - The document outlines the decision-making system for related party transactions of Shanghai Jiao Tong University Anli Co., Ltd, emphasizing the importance of fairness, transparency, and protection of minority shareholders' interests in such transactions [2][3][4]. Group 1: General Principles - The company aims to strengthen the management of related party transactions, ensuring that contracts are fair, just, and transparent [2]. - Related party transactions must adhere to principles of honesty, equality, voluntariness, and fairness, without harming the interests of the company and its shareholders [2][3]. - Written agreements are required for related party transactions, following the principles of equality, voluntariness, equivalence, and compensation [2][3]. Group 2: Definition of Related Parties - Related parties include both legal entities and natural persons that have significant control or ownership over the company [3][4]. - Legal entities that control the company directly or indirectly, or hold more than 5% of the company's shares, are classified as related parties [3][4]. - Natural persons who hold more than 5% of the company's shares or are directors and senior management are also considered related parties [3][4]. Group 3: Related Transactions - Related transactions are defined as those that may lead to the transfer of resources or obligations between the company and its related parties [6]. - The pricing of related transactions should primarily follow market prices; if unavailable, a cost-plus reasonable profit method should be used [9][10]. - Transactions exceeding certain monetary thresholds require board approval and timely disclosure [13][14]. Group 4: Disclosure and Decision-Making Procedures - Transactions with related natural persons exceeding 300,000 yuan and those with related legal entities exceeding 3 million yuan must be disclosed and approved by the board [13][14]. - The company must ensure that independent directors are involved in the review of related transactions to maintain objectivity [12][13]. - Related parties must abstain from voting on matters concerning their transactions to avoid conflicts of interest [11][12]. Group 5: Daily Management of Related Transactions - The company can estimate annual daily related transaction amounts and must disclose any amounts exceeding these estimates [27][28]. - For ongoing daily related transactions, the company must report on their execution in annual and semi-annual reports [28][29]. - If the terms of a daily related transaction change significantly, the revised agreement must be submitted for board or shareholder approval [28][29].

Core Points - The company, Zhonghua Rock and Soil, announced a financing arrangement to provide a guarantee of up to 2 billion yuan for bank loans or other financing for itself and its subsidiaries [1] - The guarantee will be valid for three years and is related to the controlling shareholder, Chengdu Xingcheng Investment Group, which holds a 29.27% stake in the company [1] - The company will provide a counter-guarantee to Chengdu Xingcheng Group through the pledge of its subsidiary equity and related assets for the portion of the guarantee exceeding the shareholding ratio [1] - The guarantee fee will be paid at a rate not exceeding 1.0% per year based on the actual guarantee amount [1] - This transaction constitutes a related party transaction due to the relationship between the company and its controlling shareholder [1]

Core Viewpoint - Zhejiang Zhenstone New Materials Co., Ltd. (Zhenstone) is attempting to re-enter the capital market after a six-year hiatus following its privatization in 2019, facing significant financial pressures and high debt levels during its IPO process [2][3][4]. Financial Performance - Zhenstone's core business focuses on the research, production, and sales of fiber-reinforced materials for clean energy, with revenue and net profit declining significantly in 2024 [3][4]. - The company's revenue figures from 2022 to 2024 were approximately 5.267 billion yuan, 5.124 billion yuan, and 4.439 billion yuan, respectively, while net profits were about 774 million yuan, 790 million yuan, and 608 million yuan [3][4]. Debt Levels - As of the end of 2024, Zhenstone's total short-term and long-term borrowings exceeded 4 billion yuan, with an asset-liability ratio consistently higher than the industry average by about 12 percentage points [2][4]. - The asset-liability ratios for the respective years were 71.53%, 71.3%, and 67.75%, compared to industry averages of 58.11%, 52.6%, and 55.7% [4]. Dividend Payments - Prior to the IPO application, Zhenstone distributed substantial cash dividends totaling approximately 1.14 billion yuan over two years, raising concerns about its financial management amid rising debt [5][6]. - The cash dividends for 2022 and 2023 were approximately 540 million yuan and 600 million yuan, representing 69.77% and 75.95% of the respective net profits [6]. Related Party Transactions - Zhenstone's supply chain exhibits a high concentration of related party transactions, with over 68% of its operating costs linked to purchases from related parties, particularly China Jushi [8][10]. - The company purchased goods and services from related parties amounting to 2.643 billion yuan, 2.185 billion yuan, and 2.235 billion yuan from 2022 to 2024, with respective proportions of 66.29%, 57.95%, and 68.59% of operating costs [10]. Governance and Control - The actual controllers of Zhenstone, Zhang Yuqiang and Zhang Jiankang, hold a combined 96.51% stake in the company, raising questions about governance and potential conflicts of interest [5][6].

证券代码：002440 证券简称：闰土股份 公告编号：2025-031 浙江闰土股份有限公司 （一）本次对外投资的基本情况 浙江闰土股份有限公司（以下简称"公司"）拟与专业投资机构西安禾盈创 业投资有限公司（以下简称"禾盈创业"）及浙江巍华新材料股份有限公司（以 下简称"巍华新材"）共同向扬州鼎龙启顺股权投资合伙企业（有限合伙）（以 下简称"合伙企业"或"标的基金"）进行投资。全体合伙人拟认购出资总额不 超过人民币95,000万元，其中公司拟作为有限合伙人以自有资金的方式认缴出资 人民币4,000万元，占合伙企业认缴出资总额的4.21%。公司拟作为有限合伙人不 执行合伙企业事务，不对外代表合伙企业，不对合伙企业产生实际控制。公司无 权向合伙企业投资决策委员会委派代表，对合伙企业的财务和经营政策不享有参 与决策的权力，对合伙企业不构成重大影响。 （二）本次对外投资构成公司与关联方共同投资的关联交易 关于公司拟与专业投资机构及关联方共同投资 暨关联交易的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 重要内容提示： • 拟投资标的名称：扬州鼎龙启顺股权投资合 ...

Core Viewpoint - The company, Hotgen Biotech (688068.SH), has approved a capital increase for its associate company, Shunjing Pharmaceutical, through a board meeting held on August 12, 2025, involving a total investment of 100 million yuan [1] Group 1: Capital Increase Details - The capital increase will be priced at 25 yuan per registered capital, raising Shunjing Pharmaceutical's registered capital from 72 million yuan to 76 million yuan [1] - After the capital increase, the company's equity stake in Shunjing Pharmaceutical will decrease from 45.5833% to 43.1842% [1] - The company has decided to waive its preferential subscription rights for this capital increase [1] Group 2: Related Party Transactions - Shunjing Pharmaceutical is an associate company in which the company holds a 45.5833% stake [1] - Lin Changqing, the company's controlling shareholder and actual controller, is also the legal representative and chairman of Shunjing Pharmaceutical, indicating a related party relationship [1] - The company's decision to waive its preferential subscription rights constitutes a related party transaction under the Shanghai Stock Exchange's regulations [1]

证券代码：000545 证券简称：金浦钛业 公告编号：2025－081 金浦钛业股份有限公司 公司因筹划重大资产置换、发行股份及支付现金购买资产并募集 配套资金暨关联交易事项，根据深圳证券交易所的相关规定，经公司 申请，公司股票（ 证券简称：金浦钛业，证券代码：000545）自 2025 年 7 月 1 日开市起停牌，具体内容详见公司于 2025 年 7 月 1 日披露 的（ 关于筹划重大资产置换、发行股份及支付现金购买资产并募集配 套资金暨关联交易事项的停牌公告》 公告编号：2025-059）。 产置换、发行股份及支付现金购买资产并募集配套资金暨关联交易事 项的停牌进展公告》 公告编号：2025-061）。 议通过了 关于 <金浦钛业股份有限公司重大资产置换 发行股份及="发行股份及"> 支付现金购买资产并募集配套资金暨关联交易预案>及其摘要的议案》 等相关议案，具体内容详见公司于 2025 年 7 月 15 日披露的相关公 告。同日，经向深圳证券交易所申请，公司股票（ 证券简称：金浦钛 业，证券代码：000545）于 2025 年 7 月 15 日开市起复牌，具体内容 详见公司于 2025 年 7 月 1 ...

证券日报网讯 8月12日晚间，特发信息发布公告称，公司、特发信息东莞分公司及全资子公司特发东智 拟与关联方特发服务续签物业管理服务合同，合同期限为两年，物业管理服务总费用约2，046.62万 元，特发服务需向公司支付停车场承包费用约156.20万元。公司拟与特发服务签订物业管理服务合同的 事项构成关联交易。公司于8月11日召开董事会审议通过了《关于与深圳市特发服务股份有限公司续签 物业管理服务合同的关联交易议案》，本议案无需提请公司股东大会审议批准。本次关联交易不构成重 大资产重组。 （文章来源：证券日报） ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：000895 证券简称：双汇发展 公告编号：2025-21 一、重要提示 本半年度报告摘要来自半年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规划，投 资者应当到证监会指定媒体仔细阅读半年度报告全文。 所有董事均已出席了审议本报告的董事会会议。 非标准审计意见提示 1、公司简介 ■ □适用 √不适用 董事会审议的报告期利润分配预案或公积金转增股本预案 √适用 □不适用 是否以公积金转增股本 □是 √否 公司经本次董事会审议通过的利润分配预案为：以3,464,661,213股为基数，向全体股东每10股派发现金 红利6.50元（含税），送红股0股（含税），不以公积金转增股本。 董事会决议通过的本报告期优先股利润分配预案 □适用 √不适用 二、公司基本情况 2、主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 √否 ■ 3、公司股东数量及持股情况 单位：股 ■ 持股5%以上股东、前10名股东及前10名无限售流通股股东参与转融通业务出借股份情况 □适用 √不适用 前10名股东及前10名无限售流通股股东因转融通出借/归还原因 ...